Immune Therapeutics Signs Binding Letter of Intent to Acquire Chinese CAR-T Technology and Clinical Data
ORLANDO, FL -- (Marketwired) -- 04/21/16 -- Immune Therapeutics Inc. (OTCQB: IMUN) today announced that they have signed a binding Letter of Intent to acquire Chinese Chimeric Super Antigen Receptor T cell (CAR-T) cocktail therapy, Immuno-Oncology patents …